UNC Health Medication Formulary
Add Formweb to your mobile device
System Formulary Update
Cerliponase alfa (Brineura)
September 30, 2025
Situation
Cerliponase alfa (Brineura) was approved for addition to the UNC Health system formulary with restriction to outpatient/clinic use following a benefits investigation prior to first dose at the September 2025 System Pharmacy and Therapeutics Committee meeting.
Background
The following medication was reviewed: Cerliponase alfa (Brineura)
Assessment/Recommendation
Change effective: Tuesday, November 11, 2025
System P&T voted to include the following products on the UNC Health Medication Formulary: Cerliponase alfa (Brineura) with the following restrictions: outpatient/clinic use following a benefits investigation prior to first dose